Big Pharma's Full Buck Moon
July 21, 2016 at 04:22 AM EDT
One could argue that Biotechnology as last to join the herd, makes it the most vulnerable. Heading into the last two sessions of the week, I will watch to see if IBB gains momentum thus strengthening the rest of the herd.
